Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis
Related Experiment Video
Updated: Aug 16, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Michael A Ko1, Carla O Rosario, John W Hudson
1Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 600 University Ave. R988, Toronto, Ontario M5G 1X5, Canada.
Abstract:
The polo-like kinase Plk4 (also called Sak) is required for late mitotic progression, cell survival and postgastrulation embryonic development. Here we identified a phenotype resulting from Plk4 haploinsufficiency in Plk4 heterozygous cells and mice. Plk4+/- embryonic fibroblasts had increased centrosomal amplification, multipolar spindle formation and aneuploidy compared with wild-type cells. The incidence of spontaneous liver and lung cancers was approximately 15 times high in elderly Plk4+/- mice than in Plk4+/+ littermates. Using the in vivo model of partial hepatectomy to induce synchronous cell cycle entry, we determined that the precise regulation of cyclins D1, E and B1 and of Cdk1 was impaired in Plk4+/- regenerating liver, and p53 activation and p21 and BubR1 expression were suppressed. These defects were associated with progressive cell cycle delays, increased spindle irregularities and accelerated hepatocellular carcinogenesis in Plk4+/- mice. Loss of heterozygosity occurs frequently (approximately 60%) at polymorphic markers adjacent to the PLK4 locus in human hepatoma. Reduced Plk4 gene dosage increases the probability of mitotic errors and cancer development.
Insights
Reduced polo-like kinase 4 (Plk4) gene dosage in mice leads to increased cancer risk. Plk4 haploinsufficiency causes mitotic errors, aneuploidy, and accelerates hepatocellular carcinogenesis, highlighting Plk4
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- Polo-like kinase 4 (Plk4) is essential for mitotic progression, cell survival, and embryonic development.
- Plk4's role in maintaining genomic stability and its implications in cancer development are not fully understood.
Purpose of the Study:
- To investigate the phenotypic consequences of Plk4 haploinsufficiency in cellular and animal models.
- To determine the impact of reduced Plk4 gene dosage on mitotic fidelity, cell cycle regulation, and cancer development.
Main Methods:
- Analysis of Plk4 heterozygous (Plk4+/-) embryonic fibroblasts and mice.
- Assessment of centrosomal amplification, spindle formation, and aneuploidy.
- In vivo partial hepatectomy model to study cell cycle regulation in regenerating liver.
- Evaluation of cyclin and Cdk1 regulation, p53 activation, and expression of p21 and BubR1.
- Analysis of spontaneous tumor incidence and loss of heterozygosity at the PLK4 locus in human hepatoma.
Main Results:
- Plk4+/- cells exhibited increased centrosomal amplification, multipolar spindles, and aneuploidy.
- Plk4+/- mice showed a 15-fold higher incidence of spontaneous liver and lung cancers.
- Impaired regulation of cyclins D1, E, B1, and Cdk1, suppressed p53 activation, p21, and BubR1 expression in Plk4+/- regenerating liver.
- Defects led to progressive cell cycle delays, spindle irregularities, and accelerated hepatocellular carcinogenesis.
- Frequent loss of heterozygosity at the PLK4 locus in human hepatoma suggests a similar mechanism.
Conclusions:
- Plk4 haploinsufficiency compromises mitotic fidelity and cell cycle control, leading to genomic instability.
- Reduced Plk4 gene dosage significantly increases susceptibility to cancer, particularly hepatocellular carcinoma.
- These findings underscore the critical role of Plk4 in preventing cancer development and highlight the clinical relevance of PLK4 locus alterations in human hepatoma.
Related Concept Videos
Abnormal Proliferation
Cytoskeletal Linker Proteins - Plakins
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
